Pirobec Foam 1% Piroxicam Joint Pain Skin 50g

Foam based on piroxicam.

Therapeutic indications

Pirobec Foam is used in the treatment of painful and inflammatory conditions of a rheumatic or traumatic nature of the joints, muscles, tendons and ligaments.

Dosage and Posology

The drug should be taken according to the following doses and methods:

• Adults: Apply Pirobec 1% foam 2-3 times a day, massaging gently to promote absorption. To dispense the foam, shake the container upside down before use, then press the valve for a few seconds: the valve delivers 1-2 g / sec, sufficient for a surface of about 40 cm2.
• Pediatric population: The safety and efficacy of Pirobec 1% cutaneous foam in children have not yet been established. No data are available.

Overdose

No cases of overdose have been reported in the literature so far.

Contraindications

Hypersensitivity to the active substance or to any of the excipients.

Side effects

The use, especially if prolonged, of the product can give rise to sensitization phenomena and local irritation. Rarely immediate reactions with urticaria and bronchospasm. In this case, the treatment must be stopped. The following dermatological side effects have also been reported with the topical use of piroxicam: contact dermatitis, eczema and skin photosensitivity reactions

Pregnancy and breastfeeding

As a precaution, its use during pregnancy and lactation is not recommended. Any use is allowed only on the advice of the doctor, if he deems it absolutely necessary.

Special warnings

The amount of active ingredient absorbed through the skin does not normally reach concentrations in circulation such as to make the warnings valid and expose to the risk of side effects related to the administration of the drug systemically. The application of products for topical use, especially if prolonged, can give rise to sensitization phenomena. In the presence of hypersensitivity reactions, treatment should be interrupted and appropriate therapy instituted. Patients with asthma, chronic obstructive diseases of the bronchi, allergic rhinitis or inflammation of the nasal mucosa (nasal polyp) react with asthma attacks, local inflammation of the skin or mucosa (Quincke's edema) or urticaria to antirheumatic treatment with NSAIDs more often than others patients.

Parahydroxybenzoates present as excipients in skin foam can cause allergic reactions (even delayed). Propylene glycol present as an excipient in skin foam can cause skin irritation.

Expiry and retention

Check the expiration date indicated on the package. The expiry date indicated on the package refers to the product in intact packaging, correctly stored. Do not expose to temperatures exceeding 50 ° C. The container under pressure must not be punctured, it must not be approached, even if empty, to heat sources and direct sunlight, do not freeze.

Warning : do not use the medicine after the expiry date indicated on the package.

Composition

100 gr of Pirobec Cutaneous Foam contain:

Active principle

1 g of piroxicam

Excipients

Propylene glycol; polysorbate 80; xanthan gum; menthol; methyl p-hydroxybenzoate; propyl p-hydroxybenzoate; citric acid monohydrate; sodium hydroxide drops; titanium dioxide; 96% ethanol; purified water. Propellant: propane-butane isobutane.